[HTML][HTML] Practice recommendations for diagnosis and treatment of the most common forms of secondary hypertension
GP Rossi, V Bisogni, G Rossitto, G Maiolino… - High Blood Pressure & …, 2020 - Springer
The vast majority of hypertensive patients are never sought for a cause of their high blood
pressure, ie for a 'secondary'form of arterial hypertension. This under detection explains why …
pressure, ie for a 'secondary'form of arterial hypertension. This under detection explains why …
2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …
JW McEvoy, CP McCarthy, RM Bruno… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[HTML][HTML] The role of aldosterone in OSA and OSA-related hypertension
Y Wang, CX Li, YN Lin, LY Zhang, SQ Li… - Frontiers in …, 2022 - frontiersin.org
Obstructive sleep apnea (OSA) is regarded as an independent risk factor for hypertension.
The possible mechanism includes oxidative stress, endothelial injury, sympathetic …
The possible mechanism includes oxidative stress, endothelial injury, sympathetic …
Primary aldosteronism: where are we now? Where to from here?
JW Funder, RM Carey - Hypertension, 2022 - Am Heart Assoc
Primary aldosteronism, the most common secondary form of hypertension, is thought to be
present in≈ 5% to 10% of hypertensive adults. However, recent studies indicate that its …
present in≈ 5% to 10% of hypertensive adults. However, recent studies indicate that its …
Evaluation of a best-practice advisory for primary aldosteronism screening
S Charoensri, L Bashaw, C Dehmlow… - JAMA Internal …, 2024 - jamanetwork.com
Importance Primary aldosteronism (PA) is a common cause of secondary hypertension and
an independent risk factor for cardiovascular morbidity and mortality. Fewer than 2% to 4 …
an independent risk factor for cardiovascular morbidity and mortality. Fewer than 2% to 4 …
[HTML][HTML] Primary aldosteronism and resistant hypertension: a pathophysiological insight
F Bioletto, M Bollati, C Lopez, S Arata… - International Journal of …, 2022 - mdpi.com
Primary aldosteronism (PA) is a pathological condition characterized by an excessive
aldosterone secretion; once thought to be rare, PA is now recognized as the most common …
aldosterone secretion; once thought to be rare, PA is now recognized as the most common …
Identification of surgically curable primary aldosteronism by imaging in a large, multiethnic international study
GP Rossi, F Crimì, G Rossitto, L Amar… - The Journal of …, 2021 - academic.oup.com
Context Adrenal gland imaging is recommended by the current guidelines for the workup of
primary aldosteronism (PA). However, its diagnostic performance has not been established …
primary aldosteronism (PA). However, its diagnostic performance has not been established …
International multicenter survey on screening and confirmatory testing in primary aldosteronism
M Naruse, M Murakami, T Katabami… - European journal of …, 2023 - academic.oup.com
Objective Primary aldosteronism (PA) is one of the most frequent causes of secondary
hypertension. Although clinical practice guidelines recommend a diagnostic process, details …
hypertension. Although clinical practice guidelines recommend a diagnostic process, details …
Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism
Many of the patients with primary aldosteronism (PA) are denied curative adrenalectomy
because of limited availability or failure of adrenal vein sampling. It has been suggested that …
because of limited availability or failure of adrenal vein sampling. It has been suggested that …
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study
Aims We aimed at determining the rate of drug-resistant arterial hypertension in patients with
an unambiguous diagnosis of primary aldosteronism (PA). Moreover, we sought for …
an unambiguous diagnosis of primary aldosteronism (PA). Moreover, we sought for …